USMLE First Aid 2013 Pharm w/antibios Flashcards
Nitrates (mechanism, use, toxicity)
Cause NO release -> vasodilation (veins >>> arteries); used in angina; fast tolerance, hypotension, flushing, headache Pharmacology Cardio
Adverse effects of statins
Hepatoxicity and muscle breakdown Pharmacology Cardio
Niacin (mechanism, use, toxicity)
Inhibits lipolysis and reduces VLDL secretion, lowering LDL and raising HDL; hyperlipidemia; flushing and hyperuricemia Pharmacology Cardio
Cholestyramine, colestipol, colesevelam (mechanism, use, toxicity)
Inhibits reabsorption of bile acids -> lower LDL with slight increase in HDL; unpigmented gallbladder stones and malabsorption Pharmacology Cardio
Ezetimibe
Prevents cholesterol reabsorption -> lower LDL Pharmacology Cardio
Fibrates (gemfibrozil + -fibrates) (mechanism, use, toxicity)
Upregulates LPL -> lower triglycerides, slightly inc. HDL and slightly dec. LDL; myositis and hepatoxicity Pharmacology Cardio
Digoxin and digitoxin (mechanism, use, toxicity)
Inhibits Na/K ATPase -> indirectly inhibits Na/Ca exchanger -> inc. calcium levels -> inc. contractility; stimulates the vagus; causes cholinergic symptoms and hyperkalemia Pharmacology Cardio
Class 1A antiarrhythmics
Quinidine, procainamide, and disopyramide; inc. AP duration and QT interval; can cause torsades de pointes, cinchonism (qunidine), procainamide (drug-induced lupus) Pharmacology Cardio
Class 1B antiarrhythmics
Lidocaine, mexiletine, and tocainide; dec. AP duration especially in depolarized/ischemia tissue; best following MI Pharmacology Cardio
Class 1C antiarrhythmics
Flecainide, propafenone; no effect on AP, used in ventricular tachycardias; do not use post-MI due to risk for arrhythmias Pharmacology Cardio
Class 1 antiarrhythmics (general mechanism and toxicity)
Blocks Na channels, decreasing the slope of phase 0 depolarization; toxicity exacerbated by hyperkalemia Pharmacology Cardio
Class 2 antiarrhythmics
Beta-blockers; reduces cAMP, slowing SA and AV node activity, increases PR interval; adverse effects include impotence, asthma exacerbation, sedation Pharmacology Cardio
Class 3 antiarrhythmics
Amiodarone, ibutilide, dofetilide, sotalol; K channel blockers; inc. AP duration and QT interval Pharmacology Cardio
Toxicity of amiodarone
Pulmonary fibrosis, hepatotoxicity, thyroid dysfunction Pharmacology Cardio
Class 4 antiarrhythmics
Ca channel blockers; verapamil and diltiazem; dec. conduction velocity and inc. PR interval; cause constipation, flushing, and edema Pharmacology Cardio
Adeosine (mechanism, use, toxicity)
Inc. K efflux, hyperpolarizing the cell; used in supraventricular tachycardias; can cause flushing, hypotension, and chest pain Pharmacology Cardio
Magnseium (mechanism, use, toxicity)
Used in torsades de pointes and digoxin toxicity Pharmacology Cardio
Treatment for prolactinoma
Bromocriptine or cabergoline (dopamine agonists) Pharmacology Endocrine
Treatment of secondary hyperaldosteronism
Spironolactone (or other AT2 antagonist) Pharmacology Endocrine
Treatment of carcinoid syndrome
Octreotide (somatostatin analogues) Pharmacology Endocrine
Rapid-acting insulins (3)
Lispro, aspart, and glulisine Pharmacology Endocrine
Short-acting insulin (1)
Regular Pharmacology Endocrine
Intermediate-acting insulin (1)
NPH Pharmacology Endocrine
Long-acting insulins (2)
Glargine and detemir Pharmacology Endocrine
Metformin (mechanism, use, toxicity)
Biguanide; unknown mechanism; increases insulin sensitivity and glycolysis and decreases gluconeogenesis; can cause lactic acidosis (don’t use in renal failure patients) Pharmacology Endocrine
Tolbutamide, chlorpropamide (mechanism, use, toxicity)
First-generation sulfonylureas; close beta-cell K channels, causing depolarization and increased insulin release; causes disulfuram-like effects Pharmacology Endocrine
Glyburide, glimepiride, glipizide (mechanism, use, toxicity)
Second-generation sulfonylureas; close beta-cell K channels, causing depolarization and increased insulin release; causes hypoglycemia Pharmacology Endocrine
Pioglitazone, rosiglitazone (mechanism, use, toxicity)
Thiazolidinediones; activates PPAR-gamma, increasing insulin sensitivity and adiponectin levels; causes weight gain, hepatotoxicity, and heart failure Pharmacology Endocrine
Acarbose, miglitol (mechanism, use, toxicity)
Alpha-glucosidase inhibitors; prevent sugar hydrolysis and absorption, reducing blood sugar levels Pharmacology Endocrine
Pramlintide (mechanism, use, toxicity)
Amylin analog; reduces glucagon secretion; causes hypoglycemia Pharmacology Endocrine
Exenatide, liraglutide (mechanism, use, toxicity)
GLP-1 analogues; increase insulin, decrease glucagon secretion; causes pancreatitis Pharmacology Endocrine
Linagliptin, saxagliptin, sitagliptin (mechanism, use, toxicity)
DPP-4 inhibitors; increase insulin, decrease glucagon secretion; causes mild urinary/respiratory infections Pharmacology Endocrine
Propylthiouracil (mechanism, use, toxicity)
Blocks thyroid peroxidase and 5’-deiodinase; used to treat hyperthyroidism; causes agranulocytosis, aplastic anemia, hepatotoxicity Pharmacology Endocrine
Methimazole (mechanism, use, toxicity)
Blocks thyroid peroxidase; used to treat hyperthyrodism; teratogenic Pharmacology Endocrine
Levothyroxine, triiodothyronine (mechanism, use, toxicity)
Thyroid hormone analogs; causes thyrotoxicosis Pharmacology Endocrine
Oxytocin (mechanism, use, toxicity)
Used to control uterine hemhorrage Pharmacology Endocrine
Demeclocycline (mechanism, use, toxicity)
ADH antagonist used to treat SIADH; can cause photosensitivty and bone/teeth abnormalities Pharmacology Endocrine
Glucocorticoids (mechanism, use, toxicity)
Inhibits phospholipase A2 activity and expression of COX-2; used for immune suppression; can cause Cushing’s syndrome, adrenal insufficiency (if withdrawn quickly) Pharmacology Endocrine
Cimetidine and ranitidine (mechanism, use, toxicity)
H2 antagonists; used to treat hyperchloridia; cimeditine is a P-450 inhibitor and has antiandrogenic effects, both reduce creatinine secretion Pharmacology GI
NAME?
Irreversibly inhibit the H/K pump; used to treat hyperchloridia; increased risk of C. difficile infection and hypomagnesemia Pharmacology GI
Bismuth, sucralfate (mechanism, use, toxicity)
Coats ulcer base and protects underlying tissue Pharmacology GI
Misoprostol (mechanism, use, toxicity)
PGE1 analog that decreases acid production and increases bicarb production; used to prevent NSAID ulcers; abortifacient Pharmacology GI
Octreotide (mechanism, use, toxicity)
Somatostatin analog; used to treat VIPoma and carcinoid syndrome Pharmacology GI
Toxicity of long-term antacid use
Hypokalemia Pharmacology GI
Infliximab (mechanism, use, toxicity)
Anti-TNF; used to treat IBD and RA; can cause activation of latent microbes Pharmacology GI
Sulfasalazine (mechanism, use, toxicity)
Combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflammatory); used to treat IBD; causes oligospermia Pharmacology GI
Ondansetron (mechanism, use, toxicity)
5-HT3 antagonist; used as an antiemetic Pharmacology GI
Metoclopramide (mechanism, use, toxicity)
D2 antagonist; used to increase gut muscle activity and as an antiemetic; causes parkinson signs Pharmacology GI
Can be used to prevent mast cell degranulation
Cromolyn sodium Pharmacology Heme/Onc
Treatment of lead poisoning
Dimercaprol and EDTA, succimer in kids Pharmacology Heme/Onc
Heparin (mechanism, use, toxicity)
Activates antithrombin, which inactivates thrombin and Xa; used for immediate coagulation and in pregnant women; some patients develop antibodies to platelet factor 4 (HIT) Pharmacology Heme/Onc
Enoxaparin, dalteparin (mechanism, use, toxicity)
Same actions as heparin, but has a longer half-life, does not have to be monitored as closely, and has a reduced risk of HIT Pharmacology Heme/Onc
Warfarin (mechanism, use, toxicity)
Inactivated gamma-carboxylation of factors II, VII, IX, X, C, and S; used for long-term and non-immediate anticoagulation; can cause tissue necrosis, teratogenic Pharmacology Heme/Onc
Alteplase, reteplase, tenecteplase (mechanism, use, toxicity)
Converts plasminogen to plasmin; used as a thrombolytic Pharmacology Heme/Onc
Aspirin (mechanism, use, toxicity)
Irreversibly inhibits COX-1 and COX-2; anti-platelet and anti-inflammatory; gastric ulcers, tinnitus, Reye’s syndrome in childhood viral infections Pharmacology Heme/Onc
Clopidogrel, ticlodipine, prasugrel, ticagrelor (mechanism, use, toxicity)
Irreversibly blocks ADP receptors on platelets, preventing degranulation; used for acure coronary syndrome; ticlodipine causes neutropenia Pharmacology Heme/Onc
Cilostazol, dipyridamole (mechanism, use, toxicity)
Phosphodiesterase inhibitor, increases cAMP and decreases ADP, preventing platelet degranulation; nausea, headache, facial flushing, hypotension Pharmacology Heme/Onc
Abciximab, eptifibatide, tirofiban (mechanism, use, toxicity)
GPIIb/IIIa inhibitors, preventing platelet aggregation; bleeding, thrombocytopenia Pharmacology Heme/Onc
Methotrexate (mechanism, use, toxicity)
Inhibits dihydrofolate reductase, inhibiting DNA synthesis; myelosuppression, macrovesicular fatty change in liver Pharmacology Heme/Onc
5-fluorouracil (mechanism, use, toxicity)
Pyrimidine analog that is activated and inhibits thymidylate synthase, inhibiting DNA synthesis; myelosuppression, photosensitivity Pharmacology Heme/Onc
Cytarabine (mechanism, use, toxicity)
Pyrimidine analog that inhibits DNA polymerase; leukopenia, thrombocytopenia, megaloblastic anemia Pharmacology Heme/Onc
Azathioprine, 6-mercaptopurine, 6-thioguanine (mechanism, use, toxicity)
Purine analogs that are activated by HGPRT and inhibit purine synthesis; toxicity is increased with allopurinol, causes bone marrow, GI, and liver toxicity Pharmacology Heme/Onc
Dactinomycin (actinomycin D) (mechanism, use, toxicity)
DNA intercalator; used for childhood tumors; myelosuppression Pharmacology Heme/Onc
Doxorubicin (Adriamycin), daunorubicin (mechanism, use, toxicity)
Generates free radicals that cause DNA strand breaks; dilated cardiomyopathy, myelosuppression, alopecia Pharmacology Heme/Onc
Bleomycin (mechanism, use, toxicity)
Generates free radicals that cause DNA strand breaks; pulmonary fibrosis with minimal myelosuppression Pharmacology Heme/Onc
Cyclophosphamide, ifosfamide (mechanism, use, toxicity)
Crosslinks DNA (must be activated by liver); myelosuppression, hemhorragic cystitis (can be minimized with mesna) Pharmacology Heme/Onc
Carmustine, lomustine, semustine, streptozocin (mechanism, use, toxicity)
Used to treat CNS tumors Pharmacology Heme/Onc
Busulfan (mechanism, use, toxicity)
Alkylates DNA; pulmonary fibrosis, hyperpigmentation Pharmacology Heme/Onc
Vincristine, vinblastine (mechanism, use, toxicity)
Block microtubule polymerization; vincristine causes neurotoxicity, vinblastine causes bone marro suppression Pharmacology Heme/Onc
Paclitaxel (mechanism, use, toxicity)
Blocks microtubule breakdown; myelosuppression Pharmacology Heme/Onc
Cisplatin, carboplatin (mechanism, use, toxicity)
Crosslinks DNA; nephrotoxicity (minimize with chloride diuresis, amifostine), acoustic n. damage Pharmacology Heme/Onc
Etoposide, teniposide (mechanism, use, toxicity)
Inhibits topoisomerase II; myelosuppression, GI upset, alopecia Pharmacology Heme/Onc
Hydroxyurea (mechanism, use, toxicity)
Inhibits ribonucleotide reductase; used in cancers and HbSS disease; bone marrow suppression Pharmacology Heme/Onc
Prednisone (mechanism, use, toxicity)
Unknown but may trigger apoptosis in dividing cells; Cushingoid symptoms Pharmacology Heme/Onc
Tamoxifen, raloxifene (mechanism, use, toxicity)
Prevents estrogen receptor binding; used in breast cancer and prevention of osteoporosis; tamoxifen increases the risk of endometrial cancer due to agonist effects Pharmacology Heme/Onc
Trastuzumab (mechanism, use, toxicity)
Antibody against HER-2 receptor; cardiotoxicity Pharmacology Heme/Onc
Imatinib (mechanism, use, toxicity)
Antibody against bcr-abl tyrosine kinase Pharmacology Heme/Onc
Rituximab (mechanism, use, toxicity)
Antibody against CD20; used to treat non-Hodgkin’s lymphoma and rheumatoid arthritis Pharmacology Heme/Onc
Vemurafenib (mechanism, use, toxicity)
B-raf kinase inhibitor (V600 mutation); used in metastatic melanoma Pharmacology Heme/Onc
Bevacizumab (mechanism, use, toxicity)
Antibody against VEGF Pharmacology Heme/Onc
Ibuprofen, naproxen, indomethacin, ketorolac, diclofenac (mechanism, use, toxicity)
Reversible COX inhibitor; gastric ulcers, renal ischemia (due to constriction of afferent arteriole) Pharmacology Musculoskeletal
Celecoxib (mechanism, use, toxicity)
Reversible COX-2 inhibitor; anti-inflammatory without damage to gastric mucosa; sulfa allergy, thrombosis Pharmacology Musculoskeletal
Acetominophen (mechanism, use, toxicity)
COX inhibitor in the CNS (not anti-inflammatory); causes hepatic necrosis Pharmacology Musculoskeletal
Alendronate (mechanism, use, toxicity)
Pyrophosphate analog that inhibits osteoclasts; used to treat osteoporosis, hypercalcemia, and Paget’s disease; corrosive esophagitis Pharmacology Musculoskeletal
Allopurinol (mechanism, use, toxicity)
Xanthine oxidase inhibitor, reduces production of uric acid Pharmacology Musculoskeletal
Febuxostat (mechanism, use, toxicity)
Xanthine oxidase inhibitor Pharmacology Musculoskeletal
Probenecid (mechanism, use, toxicity)
Inhibits reabsorption of uric acid in PCT Pharmacology Musculoskeletal
Colchine (mechanism, use, toxicity)
Inhibits microtubule polymerization, preventing neutrophil extravasation Pharmacology Musculoskeletal
Etanercept (mechanism, use, toxicity)
TNF-alpha receptor that binds free TNF-alpha Pharmacology Musculoskeletal
Infliximab, adalimumab (mechanism, use, toxicity)
Anti-TNF-alpha antibody Pharmacology Musculoskeletal
Latanoprost (mechanism, use, toxicity)
PGF2 analog that increases the outflow of aqueous humor; can cause darkening of the iris Pharmacology Neurology
Morphine, fentanyl, cofeine, heroin, methadone, meperidine, dextromethorphan, diphenoxylate (mechanism, use, toxicity)
Mu opioid agonists that open K channels and close Ca channels, inhibting synaptic transmission; addiction, respiratory depression, constipation, miosis Pharmacology Neurology
Butorphanol (mechanism, use, toxicity)
Mu opioid partial agonist; used to treat severe pain; causes withdrawal if being treated with full agonist Pharmacology Neurology
Tramadol (mechanism, use, toxicity)
Weak opioid agonist that inhibits serotonin and NE reuptake; increases risk for seizures Pharmacology Neurology
First-line therapy for simple partial seizures
Carbamazepine Pharmacology Neurology
First-line therapy for complex partial seizures
Carbamazepine Pharmacology Neurology
First-line therapies for tonic-clonic seizures (3)
Carbamazepine, phenytoin, valproate Pharmacology Neurology
First-line therapy for absence seizures
Ethosuximide Pharmacology Neurology
Phenytoin (mechanism, use, toxicity)
Increases Na channel inactivation and inhibits glutamate release; used for simple, complex, and tonic-clonic seizures and status epilecticus prophylaxis; nystagmus, gingival hyperplasia, hirsutism, megaloblastic anemia, teratogenic, drug-induced lupus, P450 inducer Pharmacology Neurology
Carbamazepine (mechanism, use, toxicity)
Increases Na channel inactivation; first-line for simple, complex, and tonic-clonic seizures and trigeminal neuralgia; agranulocytosis, aplastic anemia, P450 inducer, SIADH, liver toxicity Pharmacology Neurology
Lamotrigine (mechanism, use, toxicity)
Blocks Na channels; used for simple, complex, and tonic-clonic seizures; Steven-Johnson syndrome Pharmacology Neurology
Gabapentin (mechanism, use, toxicity)
Inhibits Ca channels; used for simple, complex, and tonic-clonic seizures, migraine prophylaxis, peripheral neuropathy, bipolar disorder; ataxia Pharmacology Neurology
Topiramate (mechanism, use, toxicity)
Blocks Na channels and increases GABA secretion; used for simple, complex, and tonic-clonic seizures and migraine prevention; mental dulling, kidney stones, weight loss Pharmacology Neurology
Phenobarbital (mechanism, use, toxicity)
Increases GABA channel action; first-line for simple, complex, and tonic-clonic seizures in children; P450 inducer Pharmacology Neurology
Valproate (mechanism, use, toxicity)
Increases Na channel inactivation and increases GABA levels; first-line for tonic-clonic seizures, used for simplex, complex, tonic-clonic, and myoclonic seizures; hepatotoxicity, neural tube defects, weight gain, tremor Pharmacology Neurology
Ethosuximide (mechanism, use, toxicity)
Blocks thalamic Ca channels; first-line for absence seizures; GI distress, Steven-Johnson syndrome Pharmacology Neurology
Benzodiazepines (mechanism, use, toxicity)
Increases frequency of GABA channel opening; first-line for status epilepticus (diazepam, lorazepam), used for eclampsia seizures (diazepam, lorazepam), anxiety, alcohol withdrawl, sleep walking, night terrors; sedation Pharmacology Neurology
Tiagabine (mechanism, use, toxicity)
Inhibits GABA reuptake; used for simple and complex seizures Pharmacology Neurology
Vigabatrin (mechanism, use, toxicity)
Irreversibly inhibits GABA transaminase, increasing GABA concentration; used for simple and complex seizures Pharmacology Neurology
Levetriacetam (mechanism, use, toxicity)
Unknown mechanism; used for simple, complex, and tonic-clonic seizures Pharmacology Neurology
Phenobarbital, pentobarbial, thiopental, secobarbital (mechanism, use, toxicity)
Increase duration of GABA channel opening; induction of anesthesia, sedative; CNS depression, P450 inducer, contraindicated in patients with porphyrias Pharmacology Neurology
Triazolam, oxazepam, midazolam (mechanism, use, toxicity)
Short-acting benzodiazepines; more addictive potential Pharmacology Neurology
Barbituates vs. benzodiazepines (mechanism)
Increase duration vs. increase frequency Pharmacology Neurology
Zolpidem, zaleplon, eszopiclone (mechanism, use, toxicity)
BZ1 subtype GABA channel agonists; used to treat insomnia Pharmacology Neurology
Ketamine (mechanism, use, toxicity)
Blocks NMDA receptor; used as an anesthetic; increases cardiac activity, hallucinations, bad dreams Pharmacology Neurology
Order of sensory loss when using local anesthetics
Pain -> temperature -> touch -> pressure Pharmacology Neurology
Succinylcholine (mechanism, use, toxicity)
ACh receptor agonist, produces sustained depolarization and desensitization; used as a paralytic; hypercalcemia, hyperkalemia, malignant hyperthermia Pharmacology Neurology
Tubocurarine, -curium drugs (mechanism, use, toxicity)
ACh antagonists; used as paralytics Pharmacology Neurology
Dantrolene (mechanism, use, toxicity)
Inhibits release of Ca from sarcoplasmic reticulum and skeletal muscle; used to treat malignant hyperthermia and neuroleptic-malignant syndrome Pharmacology Neurology
Levodopa/carbidopa (mechanism, use, toxicity)
Converted to dopamine by dopa decarboxylase in CNS/inhibits peripheral dopa decarboxylase activity; used to treat parkinson symptoms; can cause arrhythmias and “on/off” phenomenon Pharmacology Neurology
Selegiline (mechanism, use, toxicity)
MAO-B (prefers dopamine for breakdown) inhibitor, inhibits dopamine breakdown; used to treat parkinson symptoms; enhances adverse effects of levodopa Pharmacology Neurology
Donepezil, galantamine, rivastigmine (mechanism, use, toxicity)
ACh esterase inhibitors; used to treat Alzheimer’s disease; cholinergic symptoms Pharmacology Neurology
Sumatriptan (mechanism, use, toxicity)
Agonist at 1B/1D serotonin receptors; used to treat acute migraines and cluster headaches; coronary vasospasm Pharmacology Neurology
Trifluoperzine, fluphenazine, haloperidol (mechanism, use, toxicity)
High potency antipsychotics that antagonize D2 receptors; used to treat schizoprehnia, psychosis, mania, and Tourette’s; hyperprolactinemia, anti-cholinergic symptoms (dry mouth, constipation), extrapyramidal effects (dyskinesia), neuroleptic malignany syndrome, tardive dyskinesia (haloperidol) Pharmacology Psychiatry
Chlorpromazine, thioridazine (mechanism, use, toxicity)
Low potency antipsychotics that antagonize D2 receptors; used to treat schizophrenia, psychosis, mania, and Tourette’s; corneal deposits (chlorpromazine), retinal desporits (thioridazine) Pharmacology Psychiatry
Olanzapine, clozapine, quetiapine, risperidone, aripripazole, ziprasidone (mechanism, use, toxicity)
Atypical antipsychotics with unknown mechnism; used for schizophrenia, bipolar disorder, OCD, and others; weight gain (olanzapine, clozapine), agranulocytosis (clozapine), seizures (clozapine), prolonged QT (ziprasidone) Pharmacology Psychiatry
Lithium (mechanism, use, toxicity)
Unknown mechanism; used for bipolar disorder and SIADH; tremor, sedation, edema, hypothyroidism, polyuria Pharmacology Psychiatry
Buspirone (mechanism, use, toxicity)
Agonizes 1A serotonin receptors; used for generalized anxiety disorder; no side effects, but takes 1-2 weeks for improvement Pharmacology Psychiatry
Fluoxetine, paroxetine, sertraline, citalopram (mechanism, use, toxicity)
Block reuptake of serotonin from the synaptic cleft; depression and others; sexual dysfunction, sertonin syndrome (hyperthermia, myoclonus, flushing, diarrhea, seizures) Pharmacology Psychiatry
Venlafaxine, duloxetine (mechanism, use, toxicity)
Block reuptake of NE and serotonin from synaptic cleft; depression, diabetic neuropathy (duloxetine); hypertension Pharmacology Psychiatry
-iptyline, -ipramine, doxepin, amoxapine (mechanism, use, toxicity)
TCAs, block reuptake of NE and serotonin; depression, bewetting (imipramine), OCD (clomipramine); convulsions, coma, arrhythmias, sedation, hypotension, anti-cholinergic effects Pharmacology Psychiatry
Tranylcypromine, phenelzine, isocarboxazid, selegiline (mechanism, use, toxicity)
Inhibit breakdown of NE, serotonin, and dopamine; used for atypical depression, anxiety, and hypochondriasis; hypertensive crisis (tyramine in wine/cheese), don’t use with other serotonin agonists Pharmacology Psychiatry
Bupropion (mechanism, use, toxicity)
Increases NE and dopamine; used for smoking sensation, depression; seizures Pharmacology Psychiatry
Mirtazapine (mechanism, use, toxicity)
Alpha-2 antagonist, increases NE and serotonin release, and serotonin receptor agonist; used for depression; sedation, increased appetite with weight gain; Pharmacology Psychiatry
Maprotiline (mechanism, use, toxicity)
Blocks NE reuptake; used for depression; sedation, hypotension Pharmacology Psychiatry
Trazodone (mechanism, use, toxicity)
Inhibits serotonin uptake; used for insomnia; pripism Pharmacology Psychiatry
Mannitol (mechanism, use, toxicity)
Osmotic diuretic; used to treat drug overdose and increased ICP; pulmonary edema, CHF Pharmacology Renal
Acetazolamide (mechanism, use, toxicity)
Carbonic anhydrase inhibitor; used for glaucoma, metabolic alklalosis; hyperchloremic metabolic acidosis, ammonia toxicity, sulfa allergy Pharmacology Renal
Furosemide (mechanism, use, toxicity)
Inhibits NKCC channel, preventing urine concentration; used in hypertension, CHF, hypercalcemia; ototoxicity, hypokalemia, hypocalcemia, nephritis, gout, sulfa allergy Pharmacology Renal
Ethacrynic acid (mechanism, use, toxicity)
Inhibits NKCC channel; used in patients with furosemide (sulfa) allergy; hyperuricemia Pharmacology Renal
Hydrochlorothiazide (mechanism, use, toxicity)
Inhibits NaCl reabsorption in DCT and increases Ca reabsorption; hypertension and hypercalcinuria; hyperglycemia, hyperlipidemia, hyperuricemia, hypercalcemia, sulfa allergy Pharmacology Renal
Spironolactone, eplerenone (mechanism, use, toxicity)
Aldosterone receptor antagonists; hyperaldosteronism, CHF, hypokalemia; hyperkalemia (arrhythmias), antiandrogen effects with spironolactone Pharmacology Renal
Triamterene, amiloride (mechanism, use, toxicity)
Block sodium channels in cortical collecting duct; hyperaldosteronism, CHF Pharmacology Renal
Captopril, enalapril, lisinopril (mechanism, use, toxicity)
ACE inhibitor, leads to reduced angiotensin II levels and decreases GFR; prevents heart remodeling, hypertension, CHF; cough, angioedema, transient creatinine increase, hyperkalemia Pharmacology Renal
Losartan, valsartan (mechanism, use, toxicity)
Angiotensin II receptor antagonists; similar to ACE inhibitors, but do not cause cough due to normal metabolism of bradykinin Pharmacology Renal
Leuprolide (mechanism, use, toxicity)
GnRH analog that acts as an agonist in pulsatile doses and an antagonist in continuous doses; used as an agonist for infertility and an antagonist for prostate cancer, fibroids, and precocious puberty; antiandrogenic Pharmacology Reproductive
Finasteride (mechanism, use, toxicity)
5-alpha reductase inhibitor; used for BPH and male-pattern baldness Pharmacology Reproductive
Flutamide (mechanism, use, toxicity)
Testosterone receptor antagonist; used in prostate cancer Pharmacology Reproductive
Ketoconazole (mechanism, use, toxicity)
Inhibits 17,20-desmolase, stopping sex steroid synthesis; used to treat polycystic ovarian syndrome Pharmacology Reproductive
Clomiphene (mechanism, use, toxicity)
Partial estrogen agonist in the hypothalamus, increases release of LH and FSH, stimulating ovulation; used for infertility and PCOS Pharmacology Reproductive
Tamoxifen (mechanism, use, toxicity)
Estrogen receptor antagonist at the breast; used for breast cancer; partial agonist at the uterus, can cause endometrial hyperplasia Pharmacology Reproductive
Raloxifene (mechanism, use, toxicity)
Estrogen receptor agonist at bone, inhibits osteoclast activity and stimulates osteoblast activity; used to treat osteoporosis Pharmacology Reproductive
Anastrozole, exemestane (mechanism, use, toxicity)
Aromatase inhibitors; used in breast cancer Pharmacology Reproductive
Mifepristone (mechanism, use, toxicity)
Progesterone receptor antagonist, given with misoprostol for abortion; abortifacient; bleeding, abdominal pain Pharmacology Reproductive
Terbutaline (mechanism, use, toxicity)
Beta-2 agonist, inhibits uterine contractions Pharmacology Reproductive
Tamsulosin (mechanism, use, toxicity)
Alpha-1 antagonist; used to treat BPH Pharmacology Reproductive
Sildenafil, vardenafil (mechanism, use, toxicity)
Phosphodiesterase 5 inhibitors, causing inc. cGMP levels and smooth muscle relaxation; used in erectile dysfunction; impaired blue-green vision, contradindicated with nitrates Pharmacology Reproductive
Danazol (mechanism, use, toxicity)
Partial androgen receptor agonist; used to treat endometriosis and hereditary angioedema; weight gain, acne, hirsutism, low HDL, hepatoxicity Pharmacology Reproductive
Treat methemoglobinemia with
Methylene blue Pharmacology Respiratory
Diphenhydramine, dimenhydrinate, chlorpheniramine (mechanism, use, toxicity)
(First generation) H1 antagonists; used in allergies, motion sickness, insomnia; sedation, antiadrenergic, antiserotonergic, and antimuscarinic effects due to CNS penetration Pharmacology Respiratory